Cathelicidin preserves intestinal barrier function in polymicrobial sepsis

[1]  S. Wenzel,et al.  High-Dose Vitamin D3 for Critically Ill Vitamin D-Deficient Patients. , 2019, The New England journal of medicine.

[2]  R. Hyzy,et al.  Early High-Dose Vitamin D3 for Critically Ill, Vitamin D-Deficient Patients. , 2019, The New England journal of medicine.

[3]  Hiroki Tanaka,et al.  Hyaluronidase inhibits reactive adipogenesis and inflammation of colon and skin. , 2018, JCI insight.

[4]  R. Claus,et al.  Acid Sphingomyelinase Inhibition Stabilizes Hepatic Ceramide Content and Improves Hepatic Biotransformation Capacity in a Murine Model of Polymicrobial Sepsis , 2018, International journal of molecular sciences.

[5]  J. Lord,et al.  Innate and adaptive immune dysregulation in critically ill ICU patients , 2018, Scientific Reports.

[6]  M. Inglot,et al.  Liver dysfunction in sepsis. , 2018, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[7]  R. Minshall,et al.  CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury. , 2017, Journal of hepatology.

[8]  J. Schulzke,et al.  Campylobacter fetus impairs barrier function in HT‐29/B6 cells through focal tight junction alterations and leaks , 2017, Annals of the New York Academy of Sciences.

[9]  V. Nizet,et al.  Cathelicidin-deficient mice exhibit increased survival and upregulation of key inflammatory response genes following cecal ligation and puncture , 2017, Journal of Molecular Medicine.

[10]  S. Wong,et al.  Pathological Role and Diagnostic Value of Endogenous Host Defense Peptides in Adult and Neonatal Sepsis: A Systematic Review , 2017, Shock.

[11]  Ling Chen,et al.  Vitamin D both facilitates and attenuates the cellular response to lipopolysaccharide , 2017, Scientific Reports.

[12]  G. Perkins,et al.  Vitamin D Deficiency in Human and Murine Sepsis* , 2017, Critical care medicine.

[13]  Yizhen Wang,et al.  Cathelicidin-WA Improves Intestinal Epithelial Barrier Function and Enhances Host Defense against Enterohemorrhagic Escherichia coli O157:H7 Infection , 2017, The Journal of Immunology.

[14]  Jing Liu,et al.  Cathelicidin PR-39 peptide inhibits hypoxia/reperfusion-induced kidney cell apoptosis by suppression of the endoplasmic reticulum-stress pathway. , 2016, Acta biochimica et biophysica Sinica.

[15]  I. Nagaoka,et al.  Antimicrobial cathelicidin peptide LL-37 inhibits the pyroptosis of macrophages and improves the survival of polybacterial septic mice. , 2016, International immunology.

[16]  M. Weigand,et al.  Sepsis-induced long-term immune paralysis – results of a descriptive, explorative study , 2016, Critical Care.

[17]  Jun Yu,et al.  Critical Role of Antimicrobial Peptide Cathelicidin for Controlling Helicobacter pylori Survival and Infection , 2016, The Journal of Immunology.

[18]  O. Picker,et al.  Severity of polymicrobial sepsis modulates mitochondrial function in rat liver. , 2015, Mitochondrion.

[19]  Liquan Huang,et al.  Effect of Shenfu injection on intestinal mucosal barrier in a rat model of sepsis. , 2015, The American journal of emergency medicine.

[20]  Hua Wang,et al.  Vitamin D3 pretreatment alleviates renal oxidative stress in lipopolysaccharide-induced acute kidney injury , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[21]  D. Leaf,et al.  Cathelicidin antimicrobial protein, vitamin D, and risk of death in critically ill patients , 2015, Critical Care.

[22]  B. Levy,et al.  Lipoxin B4 promotes the resolution of allergic inflammation in the upper and lower airways of mice , 2014, Mucosal Immunology.

[23]  Klaus Ley,et al.  M1 and M2 Macrophages: The Chicken and the Egg of Immunity , 2014, Journal of Innate Immunity.

[24]  I. Nagaoka,et al.  Antimicrobial Cathelicidin Peptide LL-37 Inhibits the LPS/ATP-Induced Pyroptosis of Macrophages by Dual Mechanism , 2014, PloS one.

[25]  M. Kahlenberg,et al.  Little Peptide, Big Effects: The Role of LL-37 in Inflammation and Autoimmune Disease , 2013, The Journal of Immunology.

[26]  Stefan Pilz,et al.  Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. , 2013, Autoimmunity reviews.

[27]  I. Velasco,et al.  Cathelicidin LL-37 bloodstream surveillance is down regulated during septic shock. , 2013, Microbes and infection.

[28]  C. Cho,et al.  Cathelicidin protects against Helicobacter pylori colonization and the associated gastritis in mice , 2012, Gene Therapy.

[29]  N. Nesseler,et al.  The liver in sepsis , 2012 .

[30]  M. Hewison.  Antibacterial effects of vitamin D , 2011, Nature Reviews Endocrinology.

[31]  I. Nagaoka,et al.  Human anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells. , 2011, International immunology.

[32]  T. Ottenhoff,et al.  LL-37 Directs Macrophage Differentiation toward Macrophages with a Proinflammatory Signature , 2010, The Journal of Immunology.

[33]  Cole Trapnell,et al.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.

[34]  Jordi Rello,et al.  International study of the prevalence and outcomes of infection in intensive care units. , 2009, JAMA.

[35]  Jie-shou Li,et al.  Disruption of tight junctions during polymicrobial sepsis in vivo , 2009, The Journal of pathology.

[36]  C. Coopersmith,et al.  The sepsis seesaw: tilting toward immunosuppression , 2009, Nature Medicine.

[37]  G. Martin,et al.  Journal of Translational Medicine BioMed Central Review , 2008 .

[38]  M. McGuckin,et al.  Mucin Dynamics in Intestinal Bacterial Infection , 2008, PloS one.

[39]  H. Yin,et al.  Increased intestinal inflammatory response and gut barrier dysfunction in Nrf2-deficient mice after traumatic brain injury. , 2008, Cytokine.

[40]  K. Okazaki,et al.  Effect of biliary obstruction and internal biliary drainage on hepatic cytochrome P450 isozymes in rats. , 2008, World journal of gastroenterology.

[41]  Robert E. W. Hancock,et al.  Host Defense Peptide LL-37, in Synergy with Inflammatory Mediator IL-1β, Augments Immune Responses by Multiple Pathways1 , 2007, The Journal of Immunology.

[42]  John Quackenbush,et al.  Genetic basis of murine antibacterial defense to streptococcal lung infection , 2007, Immunogenetics.

[43]  M. Holick.  Vitamin D deficiency. , 2007, The New England journal of medicine.

[44]  W. Wu,et al.  A New Role for Cathelicidin in Ulcerative Colitis in Mice , 2007, Experimental biology and medicine.

[45]  M. Rocchi,et al.  LL-37 Protects Rats against Lethal Sepsis Caused by Gram-Negative Bacteria , 2006, Antimicrobial Agents and Chemotherapy.

[46]  I. Badiola,et al.  Quantification of total bacteria, enterobacteria and lactobacilli populations in pig digesta by real-time PCR. , 2006, Veterinary microbiology.

[47]  Sun-Mee Lee,et al.  Vitamins C and E protect hepatic cytochrome P450 dysfunction induced by polymicrobial sepsis. , 2006, European journal of pharmacology.

[48]  C. Coopersmith,et al.  Antibiotics Improve Survival and Alter the Inflammatory Profile in a Murine Model of Sepsis From Pseudomonas aeruginosa Pneumonia , 2003, Shock.

[49]  Takaaki Ohtake,et al.  Innate antimicrobial peptide protects the skin from invasive bacterial infection , 2001, Nature.

[50]  C. Doig,et al.  Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. , 1998, American journal of respiratory and critical care medicine.

[51]  J. Berry,et al.  Metabolism of vitamin D in patients with primary biliary cirrhosis and alcoholic liver disease. , 1985, Clinical science.

[52]  T. Denning,et al.  Macrophage Isolation from the Mouse Small and Large Intestine. , 2016, Methods in molecular biology.

[53]  D. Rittirsch,et al.  Immunodesign of experimental sepsis by cecal ligation and puncture , 2008, Nature Protocols.

[54]  M. Holick.  Medical Progress Vitamin D Deficiency , 2007 .

[55]  J. Macfie.  Current status of bacterial translocation as a cause of surgical sepsis. , 2004, British medical bulletin.

[56]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..